Li Zhu

6.0k total citations · 2 hit papers
152 papers, 4.6k citations indexed

About

Li Zhu is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Li Zhu has authored 152 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 26 papers in Cancer Research and 24 papers in Neurology. Recurrent topics in Li Zhu's work include Cancer, Hypoxia, and Metabolism (18 papers), Nanoplatforms for cancer theranostics (15 papers) and Neuroinflammation and Neurodegeneration Mechanisms (14 papers). Li Zhu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (18 papers), Nanoplatforms for cancer theranostics (15 papers) and Neuroinflammation and Neurodegeneration Mechanisms (14 papers). Li Zhu collaborates with scholars based in China, United States and Hong Kong. Li Zhu's co-authors include Yapeng Lu, Ya Ke, Zhong‐Ming Qian, Xiaomei Wu, Fang Du, Zhongping Chen, Xueting Wang, Sherven Sharma, Steven M. Dubinett and Karen L. Reckamp and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Li Zhu

144 papers receiving 4.6k citations

Hit Papers

Denosumab versus zoledron... 2018 2026 2020 2023 2018 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Zhu China 36 1.4k 758 665 602 468 152 4.6k
Joen‐Rong Sheu Taiwan 43 2.1k 1.5× 435 0.6× 411 0.6× 719 1.2× 442 0.9× 233 6.0k
Ireneusz Majsterek Poland 37 2.3k 1.6× 591 0.8× 405 0.6× 309 0.5× 200 0.4× 238 5.2k
Li Ma China 40 1.7k 1.2× 610 0.8× 363 0.5× 446 0.7× 123 0.3× 172 4.9k
Zhenyu Ju China 41 2.8k 1.9× 665 0.9× 531 0.8× 817 1.4× 240 0.5× 151 5.6k
Olivier Meilhac France 51 2.2k 1.5× 350 0.5× 272 0.4× 1.5k 2.5× 290 0.6× 217 8.0k
Giovanni G. Camici Switzerland 47 2.7k 1.9× 356 0.5× 265 0.4× 1.3k 2.2× 403 0.9× 214 7.2k
Xiao‐Kang Li Japan 38 2.1k 1.5× 384 0.5× 182 0.3× 894 1.5× 205 0.4× 190 5.1k
K. Leahy United States 27 1.7k 1.2× 787 1.0× 285 0.4× 655 1.1× 151 0.3× 63 6.4k
Jianhua Zhang United States 41 3.3k 2.3× 303 0.4× 274 0.4× 847 1.4× 237 0.5× 85 6.5k
Paula Grammas United States 45 2.1k 1.4× 418 0.6× 340 0.5× 508 0.8× 1.9k 4.1× 140 6.2k

Countries citing papers authored by Li Zhu

Since Specialization
Citations

This map shows the geographic impact of Li Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhu more than expected).

Fields of papers citing papers by Li Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhu. The network helps show where Li Zhu may publish in the future.

Co-authorship network of co-authors of Li Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Li Zhu. A scholar is included among the top collaborators of Li Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Zhu. Li Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xuanyang, Ling-Dan Dong, Li Zhu, & Wenbin Guan. (2025). Diagnostic utility of LEF1 and β-catenin in WNT pathway tumors with CTNNB1 mutation. World Journal of Surgical Oncology. 23(1). 30–30. 1 indexed citations
2.
Zhu, Li, et al.. (2025). VPS35-Retromer: Multifunctional Roles in Various Biological Processes – A Focus on Neurodegenerative Diseases and Cancer. Journal of Inflammation Research. Volume 18. 4665–4680.
3.
Weng, Lingyan, et al.. (2025). Hypoxia-Targeted Responsive Delivery of Doxorubicin and Digoxin for Synergistic Treatment of Triple-Negative Breast Cancer. Molecular Pharmaceutics. 22(4). 2142–2158. 1 indexed citations
4.
Qin, Xian, Li Zhu, Yuan Zhong, et al.. (2024). Universal cell membrane camouflaged nano-prodrugs with right-side-out orientation adapting for positive pathological vascular remodeling in atherosclerosis. Chemical Science. 15(20). 7524–7544. 9 indexed citations
5.
Zhao, Yue, et al.. (2023). Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations—Going beyond the body‐size effect. CPT Pharmacometrics & Systems Pharmacology. 13(3). 476–493. 3 indexed citations
7.
Liu, Jie, Zhigui He, Yuan Zhong, et al.. (2023). Reactive Oxygen Species-Responsive Sequentially Targeted AIE Fluorescent Probe for Precisely Identifying the Atherosclerotic Plaques. ACS Applied Materials & Interfaces. 15(40). 47381–47393. 15 indexed citations
8.
Weng, Lingyan, et al.. (2023). Effective drug and shRNA delivery for synergistic treatment of triple-negative breast cancer by sequentially targeting tumor hypoxia. Chemical Engineering Journal. 470. 144271–144271. 15 indexed citations
9.
Wang, Xueting, Zhangji Dong, Qianqian Luo, et al.. (2022). NRF1-mediated microglial activation triggers high-altitude cerebral edema. Journal of Molecular Cell Biology. 14(5). 33 indexed citations
10.
Lü, Min, Xu Huang, Xiaohui Cai, et al.. (2022). Hypoxia-Responsive Stereocomplex Polymeric Micelles with Improved Drug Loading Inhibit Breast Cancer Metastasis in an Orthotopic Murine Model. ACS Applied Materials & Interfaces. 14(18). 20551–20565. 26 indexed citations
12.
Luo, Qianqian, Jianan Hu, Guang Yang, et al.. (2020). Fasting Increases Iron Export by Modulating Ferroportin 1 Expression Through the Ghrelin/GHSR1α/MAPK Pathway in the Liver. Biological Trace Element Research. 199(1). 267–277. 5 indexed citations
13.
Yang, Lei, Dan Wang, Xueting Wang, Yapeng Lu, & Li Zhu. (2018). The roles of hypoxia-inducible Factor-1 and iron regulatory protein 1 in iron uptake induced by acute hypoxia. Biochemical and Biophysical Research Communications. 507(1-4). 128–135. 37 indexed citations
14.
Song, Zhimei, Feilong Zhou, Hongmei Xu, et al.. (2018). Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B. Carbohydrate Polymers. 205. 571–580. 26 indexed citations
15.
Luo, Qianqian, Zhong‐Ming Qian, Yufu Zhou, et al.. (2016). Expression of Iron Regulatory Protein 1 Is Regulated not only by HIF-1 but also pCREB under Hypoxia. International Journal of Biological Sciences. 12(10). 1191–1202. 10 indexed citations
16.
Lipton, Allan, Matthew Smith, Karim Fizazi, et al.. (2016). Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents. Clinical Cancer Research. 22(23). 5713–5721. 32 indexed citations
17.
Tang, Ji‐Xin, et al.. (2015). Two-step Shake-static Fermentation to Enhance Cordycepin Production by Cordyceps militaris. SHILAP Revista de lepidopterología. 46. 19–24. 9 indexed citations
18.
Zhu, Li. (2015). Comparative Antioxidant Activities of Anthocyanins Extracted from Purple Sweet Potato by Organic Solvent,Ultrasonic-Assisted and Microwave-Assisted Extraction. Food Science. 3 indexed citations
19.
Wu, Xiaomei, Zhong‐Ming Qian, Ya Ke, Fang Du, & Li Zhu. (2008). Ginkgolide B preconditioning protects neurons against ischaemia‐induced apoptosis. Journal of Cellular and Molecular Medicine. 13(11-12). 4474–4483. 24 indexed citations
20.
Baratelli, Felicita, Ying Lin, Li Zhu, et al.. (2005). Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells. The Journal of Immunology. 175(3). 1483–1490. 464 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026